Characterization of the hepatic responses to the short-term administration of ciprofibrate in several rat strains

This publication has 43 references indexed in Scilit:

• Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate
  Biochemical Pharmacology, 1988
• Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver
  Biochemical Pharmacology, 1988
• The Effect of Peroxisome Prouferators on Microsomal. Peroxisomal, and Mitochondrial Enzyme Activities in the Liver and Kidney
  Drug Metabolism Reviews, 1987
• Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans
  CRC Critical Reviews in Toxicology, 1983
• Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver
  Human Toxicology, 1983
• The carcinogenicity of dietary di(2‐ethylhexyl) phthalate (DEHP) in fischer 344 rats and B6C3F₁mice
  Journal of Toxicology and Environmental Health, 1982
• Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14, 643) in the semipurified diet
  Carcinogenesis: Integrative Cancer Research, 1981
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
  Nature, 1980
• Fatty acid oxidation by human liver peroxisomes
  Biochemical and Biophysical Research Communications, 1979
• The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug
  Atherosclerosis, 1979